paclitaxel
Showing 1 - 25 of 1,544
Ovarian Cancer Trial (albumin-bound paclitaxel, paclitaxel)
Not yet recruiting
- Ovarian Cancer
- albumin-bound paclitaxel
- paclitaxel
- (no location specified)
Mar 31, 2022
NSCLC Trial in Shanghai (Pembrolizumab, Paclitaxel, Nab-paclitaxel)
Active, not recruiting
- Non-small Cell Lung Cancer
- Pembrolizumab
- +4 more
-
Shanghai, ChinaZhongshan Hospital Fudan University
Aug 18, 2022
Breast Carcinoma Trial in Houston (biological, drug, other)
Not yet recruiting
- Breast Carcinoma
- eftilagimod alpha
- +2 more
-
Houston, TexasOncology Consultants
Feb 17, 2023
Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)
Not yet recruiting
- Biliary Tract Cancer
- +3 more
- CTX-009
- Paclitaxel
- (no location specified)
Aug 16, 2022
Breast Cancer Trial in Beijing (doxorubicin, epirubicin, pirarubicin)
Not yet recruiting
- Breast Cancer
- doxorubicin
- +6 more
-
Beijing, Beijing, ChinaCancer Hospital, ChineseAMS
Mar 17, 2022
NSCLC Trial (Pembrolizumab, Paclitaxel, Nab-paclitaxel)
Active, not recruiting
- Non-small Cell Lung Cancer
- Pembrolizumab
- +4 more
- (no location specified)
Jan 20, 2022
Ovarian Cancer, Relapsed or Refractory, Chiauranib Trial in Shanghai (chiauranib, Placebo, Paclitaxel)
Recruiting
- Ovarian Cancer
- +3 more
- chiauranib
- +2 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 7, 2022
NSCLC Trial in United States (Napabucasin, Paclitaxel)
Terminated
- Carcinoma, Non-Small-Cell Lung
- Napabucasin
- Paclitaxel
-
Beverly Hills, California
- +4 more
Apr 4, 2022
Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the
Active, not recruiting
- Human Papilloma Virus Infection
- +3 more
- paclitaxel albumin-stabilized nanoparticle formulation
- +8 more
-
Chicago, IllinoisUniversity of Chicago
Mar 2, 2022
Ovarian Cancer Trial in Houston (Paclitaxel, Bevacizumab, Lurbinectedin)
Not yet recruiting
- Ovarian Cancer
- Paclitaxel
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 23, 2022
Breast - Female, Male Breast Cancer Trial in Charlotte (Pembrolizumab, Paclitaxel)
Active, not recruiting
- Breast - Female
- Male Breast Cancer
- Pembrolizumab
- Paclitaxel
-
Charlotte, North CarolinaLevine Cancer Institute
Jul 11, 2022
Kaposi Sarcoma, HIV-1-infection Trial (Pegylated liposomal doxorubicin, Paclitaxel)
Not yet recruiting
- Kaposi Sarcoma
- HIV-1-infection
- Pegylated liposomal doxorubicin
- Paclitaxel
- (no location specified)
Jul 20, 2022
Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)
Not yet recruiting
- Small-cell Lung Cancer
- Neuroendocrine Carcinoma
- Iadademstat
- Paclitaxel
- (no location specified)
Jun 13, 2022
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial (Ramucirumab, Paclitaxel)
No longer available
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- Ramucirumab
- Paclitaxel
- (no location specified)
Aug 17, 2022
Gynecologic Malignancies Trial in Cleveland (Paclitaxel, Carboplatin)
Terminated
- Gynecologic Malignancies
- Paclitaxel
- Carboplatin
-
Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Jun 29, 2022
Peritoneal Carcinomatosis Trial in Singapore (Paclitaxel)
Not yet recruiting
- Peritoneal Carcinomatosis
- Paclitaxel
-
Singapore, SingaporeNational University Hospital
May 24, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Chemo-Induced Peripheral Neuropathy, Metastatic Breast Carcinoma Trial (Paclitaxel,
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Paclitaxel
- +4 more
- (no location specified)
Feb 21, 2023
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER Trial in United States (NAB-PACLITAXEL, PACLITAXEL)
Completed
- STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
- NAB-PACLITAXEL
- PACLITAXEL
-
Rochester, New York
- +4 more
Oct 5, 2021
Breast Cancer, Invasive Breast Cancer, Unresectable Breast Carcinoma Trial in Boston (Onvansertib, Paclitaxel)
Not yet recruiting
- Breast Cancer
- +9 more
- Onvansertib
- Paclitaxel
-
Boston, Massachusetts
- +2 more
May 16, 2022
Breast Cancer Female, Peripheral Neuropathy Trial in Cairo (Pentoxifylline, Paclitaxel, Placebo)
Recruiting
- Breast Cancer Female
- Peripheral Neuropathy
- Pentoxifylline
- +2 more
-
Cairo, Abbasia, EgyptAin Shams University hospitals
Jan 8, 2022
Peritoneal Carcinomatosis, Peritoneal Tumors, Ovarian Cancer Trial run by the National Cancer Institute (NCI) (Paclitaxel,
Not yet recruiting
- Peritoneal Carcinomatosis
- +7 more
- Paclitaxel
- Nilotinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Head and Neck Squamous Carcinoma Trial in Shanghai (SCT-I10A, SCT200, paclitaxel)
Recruiting
- Head and Neck Squamous Carcinoma
- SCT-I10A
- +3 more
-
Shanghai, ChinaShanghai East Hospital
Sep 22, 2022
Triple Negative Breast Cancer Trial in Chicago (Carboplatin, Paclitaxel, Doxorubicin)
Active, not recruiting
- Triple Negative Breast Cancer
- Carboplatin
- +3 more
-
Chicago, IllinoisUniversity of Illinois
Jan 28, 2022